BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare · Biotechnology
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | +4 | 139.04M | $1.39B | +8 | −4 |
| Q1 2026 | 108 | +4 | 130.67M | $1.24B | +14 | −10 |
| Q4 2025 | 103 | -1 | 127.11M | $991.41M | — | −1 |
| Q3 2025 | 22 | +2 | 89.66M | $680.51M | +2 | −1 |
| Q2 2025 | 18 | +1 | 80.75M | $723.56M | +1 | — |
| Q1 2025 | 14 | +1 | 26.41M | $198.06M | +1 | — |
| Q4 2024 | 13 | -2 | 21.17M | $159.22M | — | −2 |
| Q3 2024 | 14 | +4 | 16.62M | $126.32M | +4 | — |
| Q2 2024 | 10 | — | 15.77M | $97.44M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 4.71M | — | $29.12M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 4.71M | — | $29.12M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fisher Asset Management ✦ | 2.86M | — | $17.65M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.95M | — | $12.05M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.95M | — | $12.05M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.75M | — | $10.82M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 1.67M | — | $10.35M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 960.18K | — | $5.93M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (pasivo) | 651.63K | — | $4.03M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 543.24K | — | $3.36M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 543.24K | — | $3.36M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 543.24K | — | $3.36M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 350.80K | — | $2.17M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 350.80K | — | $2.17M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 317.98K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 317.98K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 298 tenedores, 245.96M acciones, $2.30B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.